PYPD
Price:
$3.94
Market Cap:
$40.15M
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Industry
Biotechnology
IPO Date
2020-06-26
Stock Exchange
NASDAQ
Ticker
PYPD
According to PolyPid Ltd.’s latest financial reports and current stock price. The company's current ROE is -454.22%. This represents a change of -82.07% compared to the average of -2533.29% of the last 4 quarters.
The mean historical ROE of PolyPid Ltd. over the last ten years is 358.72%. The current -454.22% ROE has changed -226.62% with respect to the historical average. Over the past ten years (40 quarters), PYPD's ROE was at its highest in in the December 2023 quarter at 303.24%. The ROE was at its lowest in in the March 2025 quarter at -9613.95%.
Average
358.72%
Median
4.06%
Minimum
-674.37%
Maximum
3.56%
Discovering the peaks and valleys of PolyPid Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.28%
Maximum Annual ROE = 3.56%
Minimum Annual Increase = -416.11%
Minimum Annual ROE = -674.37%
| Year | ROE | Change |
|---|---|---|
| 2024 | -377.69% | -133.17% |
| 2023 | 1.14% | -268.84% |
| 2022 | -674.37% | 500.12% |
| 2021 | -112.37% | 131.52% |
| 2020 | -48.54% | -416.11% |
| 2019 | 15.35% | -312.04% |
| 2018 | -7.24% | -111.78% |
| 2017 | 61.47% | 83.23% |
| 2016 | 33.55% | -99.06% |
| 2015 | 3.56% | 7.28% |
The current ROE of PolyPid Ltd. (PYPD) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
28.84%
5-year avg
-14.88%
10-year avg
358.72%
PolyPid Ltd.’s ROE is less than Annovis Bio, Inc. (-0.66%), less than Reviva Pharmaceuticals Holdings, Inc. (769.76%), less than BioAtla, Inc. (590.04%), greater than Evaxion Biotech A/S (-319.99%), less than Celularity Inc. (763.31%), greater than MAIA Biotechnology, Inc. (-459.68%), greater than Veru Inc. (-137.24%), greater than Actinium Pharmaceuticals, Inc. (-151.67%), less than BioXcel Therapeutics, Inc. (54.12%), less than PDS Biotechnology Corporation (-1.47%),
| Company | ROE | Market cap |
|---|---|---|
| -0.66% | $91.48M | |
| 769.76% | $40.31M | |
| 590.04% | $49.86M | |
| -319.99% | $33.41M | |
| 763.31% | $47.46M | |
| -459.68% | $44.44M | |
| -137.24% | $35.46M | |
| -151.67% | $45.23M | |
| 54.12% | $45.71M | |
| -1.47% | $43.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyPid Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PolyPid Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is PolyPid Ltd.'s ROE?
How is the ROE calculated for PolyPid Ltd. (PYPD)?
What is the highest ROE for PolyPid Ltd. (PYPD)?
What is the 3-year average ROE for PolyPid Ltd. (PYPD)?
What is the 5-year average ROE for PolyPid Ltd. (PYPD)?
How does the current ROE for PolyPid Ltd. (PYPD) compare to its historical average?